These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 7446125

  • 21. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
    Wiehlmann L, Cramer N, Ulrich J, Hedtfeld S, Weissbrodt H, Tümmler B.
    Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
    [Abstract] [Full Text] [Related]

  • 22. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Römling U, Fiedler B, Bosshammer J, Grothues D, Greipel J, von der Hardt H, Tümmler B.
    J Infect Dis; 1994 Dec; 170(6):1616-21. PubMed ID: 7996008
    [Abstract] [Full Text] [Related]

  • 23. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.
    Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC, ACPinCF Investigator Group.
    Eur Respir J; 2013 May; 41(5):1091-100. PubMed ID: 22878877
    [Abstract] [Full Text] [Related]

  • 24. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
    Schwerdt M, Neumann C, Schwartbeck B, Kampmeier S, Herzog S, Görlich D, Dübbers A, Große-Onnebrink J, Kessler C, Küster P, Schültingkemper H, Treffon J, Peters G, Kahl BC.
    Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
    [Abstract] [Full Text] [Related]

  • 25. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A, Razavi S, Irajian G, Ardebili A, Erfani Y, Solgi S, Yaghoubi S, Rasaeian A, Yahyapour Y, Kafshgari R, Shoja S, Rajabnia R.
    Infez Med; 2018 Sep 01; 26(3):226-236. PubMed ID: 30246765
    [Abstract] [Full Text] [Related]

  • 26. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
    Schmid J, Ling LJ, Leung JL, Zhang N, Kolbe J, Wesley AW, Mills GD, Brown PJ, Jones DT, Laing RT, Pattemore PK, Taylor DR, Grimwood K.
    Eur Respir J; 2008 Dec 01; 32(6):1583-90. PubMed ID: 18715877
    [Abstract] [Full Text] [Related]

  • 27. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE, Høiby N.
    Scand J Infect Dis Suppl; 1981 Dec 01; 29():87-91. PubMed ID: 6458884
    [Abstract] [Full Text] [Related]

  • 28. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
    Milczewska J, Wołkowicz T, Zacharczuk K, Kwiatkowska M.
    Dev Period Med; 2015 Dec 01; 19(1):60-5. PubMed ID: 26003071
    [Abstract] [Full Text] [Related]

  • 29. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients.
    Hall AJ, Fothergill JL, McNamara PS, Southern KW, Winstanley C.
    Diagn Microbiol Infect Dis; 2014 Dec 01; 80(4):324-6. PubMed ID: 25284374
    [Abstract] [Full Text] [Related]

  • 30. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
    Zimakoff J, Høiby N, Rosendal K, Guilbert JP.
    J Hosp Infect; 1983 Mar 01; 4(1):31-40. PubMed ID: 6190882
    [Abstract] [Full Text] [Related]

  • 31. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA, Wolfs TF, van Haren Noman S, van Aalderen WM, Nagelkerke AF, Nuijsink M, Kimpen JL, van der Ent CK.
    Thorax; 2010 Oct 01; 65(10):915-20. PubMed ID: 20729233
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis.
    Komiyama K, Tynan JJ, Habbick BF, Duncan DE, Liepert DJ.
    Oral Surg Oral Med Oral Pathol; 1985 Jun 01; 59(6):590-4. PubMed ID: 3925406
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison by extended ribotyping of Pseudomonas cepacia isolated from cystic fibrosis patients with acute and chronic infections.
    Rozee KR, Haase D, Macdonald NE, Johnson WM.
    Diagn Microbiol Infect Dis; 1994 Dec 01; 20(4):181-6. PubMed ID: 7535673
    [Abstract] [Full Text] [Related]

  • 36. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U, Wingender J, Jäger KE.
    Klin Wochenschr; 1985 Jun 03; 63(11):490-8. PubMed ID: 3925219
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML.
    JAMA; 2005 Feb 02; 293(5):581-8. PubMed ID: 15687313
    [Abstract] [Full Text] [Related]

  • 40. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.
    McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ.
    Lancet; 2001 Aug 18; 358(9281):558-60. PubMed ID: 11520530
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.